🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/03/2019 18,88 19,41 18,53 18,88 +1,40% 4,66% 1.464.300
15/03/2019 18,59 19,00 18,53 18,62 +0,38% 2,53% 2.504.800
14/03/2019 19,25 19,70 18,41 18,55 -3,89% 6,70% 1.508.600
13/03/2019 19,45 19,68 19,19 19,30 -0,10% 2,52% 1.260.300
12/03/2019 19,11 19,55 18,90 19,32 +1,36% 3,40% 1.284.800
11/03/2019 18,74 19,15 18,43 19,06 +3,53% 3,84% 1.693.100
08/03/2019 17,89 18,50 17,58 18,41 +1,54% 5,14% 1.415.500
07/03/2019 17,96 18,53 17,79 18,13 +0,72% 4,12% 1.357.000
06/03/2019 19,64 19,72 17,80 18,00 -8,35% 9,75% 2.727.300
05/03/2019 19,70 20,17 19,45 19,64 -1,01% 3,65% 1.727.800
04/03/2019 20,36 20,60 19,20 19,84 -1,68% 6,88% 1.845.400
01/03/2019 19,77 20,25 19,73 20,18 +3,38% 2,63% 1.910.700
28/02/2019 19,73 19,88 19,13 19,52 -0,91% 3,80% 1.560.500
27/02/2019 19,09 19,80 19,09 19,70 +2,87% 3,72% 1.609.600
26/02/2019 19,00 19,36 18,90 19,15 +0,16% 2,42% 2.053.000
25/02/2019 18,83 19,26 18,65 19,12 +3,91% 3,24% 1.936.400
22/02/2019 18,00 18,41 17,92 18,40 +2,11% 2,72% 1.350.000
21/02/2019 17,84 18,10 17,57 18,02 -0,44% 2,97% 1.005.800
20/02/2019 18,25 18,54 17,66 18,10 -0,17% 4,82% 1.404.400
19/02/2019 17,82 18,27 17,57 18,13 +1,17% 3,91% 1.961.600
15/02/2019 17,71 17,93 17,54 17,92 +1,76% 2,20% 1.816.900
14/02/2019 17,16 17,79 17,05 17,61 +1,91% 4,31% 1.463.300
13/02/2019 17,45 17,77 17,12 17,28 -0,40% 3,72% 2.197.200
12/02/2019 17,03 17,45 16,57 17,35 +2,54% 5,17% 2.769.800
11/02/2019 15,66 17,00 15,22 16,92 +8,05% 11,37% 3.687.200
08/02/2019 12,76 15,78 12,72 15,66 +17,74% 23,98% 5.605.800
07/02/2019 13,72 13,88 13,00 13,30 -3,90% 6,38% 1.641.900
06/02/2019 13,82 13,99 13,50 13,84 +0,22% 3,55% 570.500
05/02/2019 14,38 14,51 13,75 13,81 -3,76% 5,28% 1.110.500
04/02/2019 14,20 14,42 14,03 14,35 +0,35% 2,76% 621.500